Dihexa is a synthetic peptide derived from angiotensin IV, specifically designed to penetrate the blood-brain barrier and exhibit procognitive properties. Researchers primarily study dihexa for its potential role in enhancing cognitive function and synaptic connectivity, particularly in the context of neurodegenerative diseases such as Alzheimer's disease. Key findings from recent studies indicate that dihexa binds with high affinity to hepatocyte growth factor (HGF) and activates the c-Met receptor, leading to increased synaptogenesis and hippocampal spinogenesis. Additionally, preclinical evidence suggests that dihexa may facilitate memory consolidation and retrieval in animal models. Current research is focused on further elucidating its mechanisms of action and exploring its therapeutic potential in clinical settings.